Skip to main content
. 2017 Apr 7;7:29–31. doi: 10.1016/j.jbo.2017.04.004

Fig. 1.

Fig. 1

The amount of hits from PubMed searches per year. A: The amount of osteosarcoma in vitro studies greatly increased in the past few years, with an increased proportion of articles with Chinese authors. B: Amount of PubMed hits per year for U-2 OS (osteosarcoma), MG-63 (osteosarcoma) and HT-1080 (fibrosarcoma) demonstrates that the exponential increase in in vitro studies is not identified in other sarcomas.